Page 2 - பலதரப்பட்ட சங்கம் க்கு சைகடெலிக் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dean Drobot/Shutterstock A Vancouver-based company has received approval from Health Canada to study MDMA-assisted therapy for post-traumatic stress disorder (PTSD). Numinus, a developer of psychedelic-assisted therapies for mental health care, announced that its study had been green-lit in a release issued earlier this month. “We are thrilled that Health Canada has issued its No Objection Letter allowing this important study to proceed and, in doing so, potentially advance Canada toward a legal, regulated system for MDMA-assisted therapy,” said CEO Payton Nyquvest. Numinus’ study will look at the safety and feasibility of using MDMA-assisted therapies to treat PTSD. Researchers will collect data on the safety and effectiveness of the treatment in the hopes of making MDMA-assisted therapy available to all Canadians living with PTSD.

Payton nyquvestAmy emersonMultidisciplinary association for psychedelicPublic benefit corporationHealth canadaBenefit corporationMultidisciplinary associationஆமி எமர்சன்பலதரப்பட்ட சங்கம் க்கு சைகடெலிக்பொது நன்மை நிறுவனம்ஆரோக்கியம் கனடாநன்மை நிறுவனம்பலதரப்பட்ட சங்கம்